Plavix Charges Settled, But More May Be Coming

Law360, New York (May 11, 2007, 12:00 AM EDT) -- Now that Bristol-Myers Squibb Co. has tentatively settled criminal antitrust charges with the U.S. Department of Justice, it will wait to see whether the Federal Trade Commission or states take civil action against it over a failed Plavix patent agreement.

Bristol-Myers Squibb announced Thursday that it would plead guilty to two counts of making false statements to the government and pay a fine of up to $1 million. In return, the DOJ will not pursue more serious criminal charges against it.

“Full compliance with all of...
To view the full article, register now.